-
公开(公告)号:US09834598B2
公开(公告)日:2017-12-05
申请号:US14435520
申请日:2013-10-15
Applicant: MedImmune Limited
Inventor: Maria Groves , Suzanne Gustavsson , Kina Höglund , Chris Lloyd , Adrian Nickson , Camilla Niva , Sylvia Simon , David Lowne , Fraser Welsh , Per-Ola Freskgärd
IPC: A61K39/395 , C07K16/18 , A61P25/28 , A61K39/00
CPC classification number: C07K16/18 , A61K39/3955 , A61K2039/505 , C07K2317/21 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/55 , C07K2317/565 , C07K2317/567 , C07K2317/60 , C07K2317/622 , C07K2317/92
Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
-
公开(公告)号:US20240294619A1
公开(公告)日:2024-09-05
申请号:US18604668
申请日:2024-03-14
Applicant: MedImmune Limited
Inventor: Maria Groves , Suzanne Gustavsson , Kina Höglund , Chris Lloyd , Adrian Nickson , Camilla Niva , Sylvia Simon , David Lowne , Fraser Welsh , Per-Ola Freskgärd
IPC: C07K16/18 , A61K38/17 , A61K39/00 , A61K39/395 , A61P25/28
CPC classification number: C07K16/18 , A61P25/28 , A61K38/1716 , A61K39/3955 , A61K2039/505 , C07K2317/21 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/55 , C07K2317/565 , C07K2317/567 , C07K2317/60 , C07K2317/622 , C07K2317/92
Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
-
公开(公告)号:US20180105585A1
公开(公告)日:2018-04-19
申请号:US15793510
申请日:2017-10-25
Applicant: MedImmune Limited
Inventor: Maria Groves , Suzanne Gustavsson , Kina Höglund , Chris Lloyd , Adrian Nickson , Camilla Niva , Sylvia Simon , David Lowne , Fraser Welsh , Per-Ola Freskgärd
IPC: C07K16/18 , A61K39/395 , A61K39/00
Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
-
公开(公告)号:US20220251181A1
公开(公告)日:2022-08-11
申请号:US17673449
申请日:2022-02-16
Applicant: MedImmune Limited
Inventor: Maria Groves , Suzanne Gustavsson , Kina Höglund , Chris Lloyd , Adrian Nickson , Camilla Niva , Sylvia Simon , David Lowne , Fraser Welsh , Per-Ola Freskgard
Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
-
公开(公告)号:US20210009665A1
公开(公告)日:2021-01-14
申请号:US16864439
申请日:2020-05-01
Applicant: MedImmune Limited
Inventor: Maria Groves , Suzanne Gustavsson , Kina Höglund , Chris Lloyd , Adrian Nickson , Camilla Niva , Sylvia Simon , David Lowne , Fraser Welsh , Per-Ola Freskgärd
Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
-
公开(公告)号:US12098191B2
公开(公告)日:2024-09-24
申请号:US17673449
申请日:2022-02-16
Applicant: MedImmune Limited
Inventor: Maria Groves , Suzanne Gustavsson , Kina Höglund , Chris Lloyd , Adrian Nickson , Camilla Niva , Sylvia Simon , David Lowne , Fraser Welsh , Per-Ola Freskgard
IPC: C07K16/18 , A61K38/17 , A61K39/00 , A61K39/395 , A61P25/28
CPC classification number: C07K16/18 , A61P25/28 , A61K38/1716 , A61K39/3955 , A61K2039/505 , C07K2317/21 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/55 , C07K2317/565 , C07K2317/567 , C07K2317/60 , C07K2317/622 , C07K2317/92
Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
-
公开(公告)号:US11286297B2
公开(公告)日:2022-03-29
申请号:US16864439
申请日:2020-05-01
Applicant: MedImmune Limited
Inventor: Maria Groves , Suzanne Gustavsson , Kina Höglund , Chris Lloyd , Adrian Nickson , Camilla Niva , Sylvia Simon , David Lowne , Fraser Welsh , Per-Ola Freskgärd
IPC: C07K16/18 , A61P25/28 , A61K39/395 , A61K38/17 , A61K39/00
Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
-
公开(公告)号:US10662239B2
公开(公告)日:2020-05-26
申请号:US15793510
申请日:2017-10-25
Applicant: MedImmune Limited
Inventor: Maria Groves , Suzanne Gustavsson , Kina Höglund , Chris Lloyd , Adrian Nickson , Camilla Niva , Sylvia Simon , David Lowne , Fraser Welsh , Per-Ola Freskgärd
IPC: C07K16/18 , A61P25/28 , A61K39/395 , A61K39/00
Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
-
-
-
-
-
-
-